Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Hunan Fangsheng Pharmaceutical Co's Days Payable or its related term are showing as below:
SHSE:603998'
s Days Payable Range Over the Past 10 Years
Min: 46.75 Med: 82.65 Max: 178.75
Current: 148.52
During the past 13 years, Hunan Fangsheng Pharmaceutical Co's highest Days Payable was 178.75. The lowest was 46.75. And the median was 82.65.
SHSE:603998's Days Payable is ranked better than 75.14% of 925
companies
in the Drug Manufacturers industry
Industry Median: 89.27
vs SHSE:603998: 148.52
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hunan Fangsheng Pharmaceutical Co Days Payable Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Hunan Fangsheng Pharmaceutical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hunan Fangsheng Pharmaceutical Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hunan Fangsheng Pharmaceutical Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Hunan Fangsheng Pharmaceutical Co's Days Payable falls into.
Hunan Fangsheng Pharmaceutical Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hunan Fangsheng Pharmaceutical Co (SHSE:603998) has a Days Payable of 133.67 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Hunan Fangsheng Pharmaceutical Co and its competitors. This is 62% above median its historical median of 82.65. Over the past decade, Hunan Fangsheng Pharmaceutical Co's Days Payable has ranged from 46.75 to 178.75. According to the industry distribution chart, Hunan Fangsheng Pharmaceutical Co ranks #230 out of 925 companies in the Drug Manufacturers industry, placing it in the top 24.9%.
Is Hunan Fangsheng Pharmaceutical Co's Days Payable too high?
Hunan Fangsheng Pharmaceutical Co's current Days Payable of 133.67 is 62% above median its 10-year median of 82.65. Over the past 10 years, this metric has ranged from a low of 46.75 to a high of 178.75. The Drug Manufacturers industry median Days Payable is 89.27. Hunan Fangsheng Pharmaceutical Co's value of 133.67 is 49.7% above this industry median. Based on the distribution chart, Hunan Fangsheng Pharmaceutical Co ranks #230 out of 925 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Hunan Fangsheng Pharmaceutical Co has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hunan Fangsheng Pharmaceutical Co's Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Hunan Fangsheng Pharmaceutical Co ranks #230 out of 925 companies for Days Payable. This places Hunan Fangsheng Pharmaceutical Co in the top 25% of its industry — outperforming the majority of peers. The industry median Days Payable is 89.27. Hunan Fangsheng Pharmaceutical Co's value of 133.67 is 49.7% above this benchmark. Historically, Hunan Fangsheng Pharmaceutical Co's own Days Payable has ranged from 46.75 to 178.75 over the past decade. While the company's 10-year median is 82.65 vs. the industry median of 89.27, Hunan Fangsheng Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 89.27, based on 925 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hunan Fangsheng Pharmaceutical Co's current Days Payable of 133.67 is 49.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Hunan Fangsheng Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 89.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hunan Fangsheng Pharmaceutical Co's current Days Payable is 133.67, which is 62% above median its own 10-year median of 82.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hunan Fangsheng Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Hunan Fangsheng Pharmaceutical Co (SHSE:603998) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥12.06, compared to a current price of ¥10.78 — trading 10.6% below its estimated fair value. The current Days Payable is 133.67, which is 62% above median its 10-year median of 82.65 and 49.7% above the Drug Manufacturers industry median of 89.27. Hunan Fangsheng Pharmaceutical Co's overall GF Score™ is 86/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Hunan Fangsheng Pharmaceutical Co (SHSE:603998), the current Days Payable is 133.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hunan Fangsheng Pharmaceutical Co (SHSE:603998) Overvalued in 2026?
Based on GuruFocus' analysis, Hunan Fangsheng Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥10.78 is trading 10.6% below its estimated GF Value™ of ¥12.06.
GuruFocus considers Hunan Fangsheng Pharmaceutical Co to be Modestly Undervalued.
Key valuation signals for SHSE:603998:
Days Payable: 133.67 (62% above median its 10-year median of 82.65)
GF Value™: ¥12.06 vs. price of ¥10.78 (10.6% below fair value)
Industry Position: 49.7% above the Drug Manufacturers median (#230 of 925)
No single metric tells the full story. See the SHSE:603998 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hunan Fangsheng Pharmaceutical Co Ltd is engaged in pharmaceutical business. The company's business scope covers the production and sales of tablets, capsules, granules, oral suspension, powder, suppository, powder-injection, tinctures, spray lotion, small volume injections, and bulk pharmaceutical chemicals. Its product offerings include Cefixime Tablets, Cefpiramide for Injection, Cefprozil Tablets, Fleroxacin Dispersible Tablets, and others.
86GF Score
Get the complete analysis for SHSE:603998
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603998 has been successfully added to your 
